Base-edited CAR T-cell therapy shows promise for relapsed, refractory childhood ALL
![T-Cells Work to Fight Cancer](https://www.medwirenews.com/wp-content/uploads/2023/09/AdobeStock_433344680-crop.jpg)
Base-edited chimeric antigen receptor T-cell therapy is feasible for the treatment of relapsed or refractory childhood T-cell acute lymphoblastic leukemia, suggests research published in The New England Journal of Medicine.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.